We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

242 hedge funds and large institutions have $730M invested in Aurinia Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 63 increasing their positions, 90 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

135% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 20

82% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $8.82M

47% more capital invested

Capital invested by funds: $497M → $730M (+$233M)

11% more funds holding

Funds holding: 219 → 242 (+23)

6.75% more ownership

Funds ownership: 43.43% → 50.17% (+6.7%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

30% less repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 90

Holders
242
Holders Change
+23
Holders Change %
+10.5%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
47
Increased
63
Reduced
90
Closed
20
Calls
$16.1M
Puts
$8.82M
Net Calls
+$7.23M
Net Calls Change
+$1.76M

Top Buyers

Rank Fund Capital Flow
1
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$25.1M
2
Marshall Wace
Marshall Wace
United Kingdom
+$15M
3
TCM
Tang Capital Management
California
+$14.2M
4
Two Sigma Investments
Two Sigma Investments
New York
+$12.9M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$8.95M

Top Sellers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
-$13.8M
2
RAM
Readystate Asset Management
Illinois
-$5.57M
3
Morgan Stanley
Morgan Stanley
New York
-$4.91M
4
Lazard Asset Management
Lazard Asset Management
New York
-$4.84M
5
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$3.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
Public Employees Retirement Association of Colorado
151
Public Employees Retirement Association of Colorado
Colorado
$216K -$19.8K -1,813 -8%
ET
152
Entropy Technologies
New York
$203K +$201K +18,359 New
Citigroup
153
Citigroup
New York
$194K -$369K -33,791 -66%
VA
154
Vident Advisory
Georgia
$182K -$1.57K -144 -0.9%
MF
155
Magnetar Financial
Illinois
$176K +$174K +15,947 New
ML
156
Mayport LLC
Massachusetts
$173K +$171K +15,700 New
Toronto Dominion Bank
157
Toronto Dominion Bank
Ontario, Canada
$169K – – –
Cerity Partners
158
Cerity Partners
New York
$167K +$165K +15,089 New
Carson Wealth (CWM LLC)
159
Carson Wealth (CWM LLC)
Nebraska
$158K -$15.9K -1,458 -9%
Mariner
160
Mariner
Kansas
$157K +$155K +14,173 New
VPIM
161
Vanguard Personalized Indexing Management
California
$154K +$32.5K +2,973 +27%
MML Investors Services
162
MML Investors Services
Massachusetts
$153K -$15.6K -1,428 -9%
Commonwealth Equity Services
163
Commonwealth Equity Services
Massachusetts
$151K +$149K +13,634 New
JGC
164
J. Goldman & Co
New York
$149K +$147K +13,500 New
OC
165
Oppenheimer & Co
New York
$148K – – –
Pictet Asset Management
166
Pictet Asset Management
Switzerland
$137K – – –
CBU
167
CIBC Bancorp USA
Illinois
$137K +$136K +12,414 New
UBP
168
Union Bancaire Privee
Switzerland
$136K +$142K +13,000 New
BWM
169
BCS Wealth Management
Tennessee
$134K – – –
Wealth Enhancement Advisory Services
170
Wealth Enhancement Advisory Services
Minnesota
$134K -$17.2K -1,571 -12%
US Bancorp
171
US Bancorp
Minnesota
$132K -$448 -41 -0.3%
B
172
Bailard
California
$129K – – –
TSS
173
Two Sigma Securities
New York
$128K -$31.9K -2,920 -20%
GCP
174
GSA Capital Partners
United Kingdom
$127K -$2.93M -267,954 -96%
Mackenzie Financial
175
Mackenzie Financial
Ontario, Canada
$118K – – –
5 6
7
8 9

AUPH Hedge Fund Activity: Q3 2025 in Review

242 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q3 2025, worth a combined $730M — up 47% from $497M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new AUPH positions and 20 closed out — a net gain of 27 holders — while 63 added to existing stakes and 90 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $25.1M. The largest seller was Armistice Capital, exiting entirely with an estimated $13.8M sold.

  • 242 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q3 2025, up from 219 in Q2 2025.
  • Funds reported $730M of Aurinia Pharmaceuticals stock for Q3 2025, up 47% quarter-over-quarter.
  • 47 funds opened new Aurinia Pharmaceuticals positions in Q3 2025 and 20 closed out, a net change of +27 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q3 2025 was Arrowstreet Capital, an estimated $25.1M added.
  • The largest Aurinia Pharmaceuticals seller in Q3 2025 was Armistice Capital, an estimated $13.8M sold.

Based on aggregated 13F filings for Q3 2025.